View in EDS HTML Full Text PDF Full Text

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.

Saved in:
Bibliographic Details
Title: PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Authors: Abdulla M; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden., Alexsson A; Clinical Genomics Uppsala, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Sundström C; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden., Ladenvall C; Clinical Genomics Uppsala, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Lindskog C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Berglund M; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Cavelier L; Clinical Genomics Uppsala, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Enblad G; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Hollander P; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden., Amini RM; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden.
Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Apr; Vol. 60 (4), pp. 531-538. Date of Electronic Publication: 2021 Feb 12.
Publication Type: Journal Article
Journal Info: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33579170
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abdulla+M%22">Abdulla M</searchLink>; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Alexsson+A%22">Alexsson A</searchLink>; Clinical Genomics Uppsala, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Sundström+C%22">Sundström C</searchLink>; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Ladenvall+C%22">Ladenvall C</searchLink>; Clinical Genomics Uppsala, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Mansouri+L%22">Mansouri L</searchLink>; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lindskog+C%22">Lindskog C</searchLink>; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Berglund+M%22">Berglund M</searchLink>; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Cavelier+L%22">Cavelier L</searchLink>; Clinical Genomics Uppsala, Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Enblad+G%22">Enblad G</searchLink>; Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Hollander+P%22">Hollander P</searchLink>; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Amini+RM%22">Amini RM</searchLink>; Clinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228709065%22">Acta oncologica (Stockholm, Sweden)</searchLink> [Acta Oncol] 2021 Apr; Vol. 60 (4), pp. 531-538. <i>Date of Electronic Publication: </i>2021 Feb 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Medical+Journals+Sweden+AB%22">Medical Journals Sweden AB </searchLink><i>Country of Publication: </i>Sweden <i>NLM ID: </i>8709065 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1651-226X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220284186X%22">0284186X </searchLink><i>NLM ISO Abbreviation: </i>Acta Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33579170
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/0284186X.2021.1881161
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 531
    Titles:
      – TitleFull: PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abdulla M
      – PersonEntity:
          Name:
            NameFull: Alexsson A
      – PersonEntity:
          Name:
            NameFull: Sundström C
      – PersonEntity:
          Name:
            NameFull: Ladenvall C
      – PersonEntity:
          Name:
            NameFull: Mansouri L
      – PersonEntity:
          Name:
            NameFull: Lindskog C
      – PersonEntity:
          Name:
            NameFull: Berglund M
      – PersonEntity:
          Name:
            NameFull: Cavelier L
      – PersonEntity:
          Name:
            NameFull: Enblad G
      – PersonEntity:
          Name:
            NameFull: Hollander P
      – PersonEntity:
          Name:
            NameFull: Amini RM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2021 Apr
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1651-226X
          Numbering:
            – Type: volume
              Value: 60
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Acta oncologica (Stockholm, Sweden)
              Type: main
ResultId 1